Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2021-2022
Canada
The specific objective(s) of this funding opportunity are to:
• Support the development of structured, openly accessible and sustainable training and mentoring platforms that build capacity in areas...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2023-2024
Canada
The specific objectives of this funding opportunity are to:
1. Mobilize and scale-up newly generated and existing knowledge and models of care into effective, gender-sensitive and culturally approp...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
Canada
Fluconazole and adverse effects of pregnancy
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2018-2019
Canada
Canadian Multi-Province Cohorts of Pregnant Women and Children
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2021-2022
Canada
This is a directed grant funding opportunity to the Health Research Training Platform (HRTP) Pilot grantees, for funding for patient engagement enhancement activities to be funded through the SPOR rin...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada
Antidepressant use during pregnancy and the risk of pregnancy induced hypertension, gestational diabetes, and post-partum depression.
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
Highly active anti-retroviral therapy use during pregnancy and the risk of mother-to-child transmission, congenital malformation, and neonatal death
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
SNRI, bupropion and mirtazapine use during pregnancy and the risk of persistent pulmonary hypertension of the newborn (PPHN)
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
Canada
Use of ondansetron in pregnancy and the risk of fetal abnormalities
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2019-2020
Canada
The specific objectives of this funding opportunity are:
• to support planning activities, partnership development and/or increasing understanding of the health research landscape that will contrib...
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2024-2025
Canada
The funding supplement is intended to further support and/or enhance ongoing Hub activities. These activities could include but are not limited to: development of knowledge mobilization tools, sharing...